Calquence is under clinical development by AstraZeneca and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Oral Cavity (Mouth) Cancer.

In a trailblazing advancement in cancer therapy, researchers at Korea Advanced Institute of Science and Technology (KAIST) have developed a technology that transforms colon cancer cells into ...

Estimated numbers of new cancer cases and deaths in 2020 (In 2020, there will be an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States.) Current cancer ...

Since Mars is rolling retrograde in Leo now and will backpedal into Cancer on the 6th, create a smart budget the first quarter of the year. Zero in on your spending habits and trim the fat.

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

An authority figure can strike a nerve in you today. Don’t take the bait under the Capricorn moon. Who do they think they are anyway? Avoid a conflict based on someone else’s issues.

It is possible that AtLP represent multiclonal B cells, T cells or NK-cell lymphoproliferative processes ... alterations likely result from loss of tumor-suppressor genes, activation of oncogenes ...